Nisa Investment Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.91K Hold
80
﹤0.01% 2536
2025
Q1
$2.9K Hold
80
﹤0.01% 2374
2024
Q4
$3.37K Hold
80
﹤0.01% 2360
2024
Q3
$4.44K Hold
80
﹤0.01% 2240
2024
Q2
$3.29K Hold
80
﹤0.01% 2315
2024
Q1
$3.74K Hold
80
﹤0.01% 2150
2023
Q4
$3.83K Hold
80
﹤0.01% 2142
2023
Q3
$2.85K Hold
80
﹤0.01% 2324
2023
Q2
$3.69K Sell
80
-130
-62% -$6K ﹤0.01% 2340
2023
Q1
$8K Hold
210
﹤0.01% 2192
2022
Q4
$10K Hold
210
﹤0.01% 2209
2022
Q3
$8K Sell
210
-8,323
-98% -$317K ﹤0.01% 2234
2022
Q2
$509K Buy
8,533
+8,100
+1,871% +$483K ﹤0.01% 1051
2022
Q1
$31K Sell
433
-1,396
-76% -$99.9K ﹤0.01% 1963
2021
Q4
$128K Buy
1,829
+127
+7% +$8.89K ﹤0.01% 1421
2021
Q3
$154 Sell
1,702
-2,070
-55% -$187 ﹤0.01% 1515
2021
Q2
$360 Sell
3,772
-1,450
-28% -$138 ﹤0.01% 1226
2021
Q1
$595 Hold
5,222
﹤0.01% 1123
2020
Q4
$723K Buy
5,222
+3,337
+177% +$462K ﹤0.01% 1052
2020
Q3
$155K Buy
1,885
+1,450
+333% +$119K ﹤0.01% 1396
2020
Q2
$34K Buy
435
+50
+13% +$3.91K ﹤0.01% 1659
2020
Q1
$17K Buy
385
+100
+35% +$4.42K ﹤0.01% 1741
2019
Q4
$12K Hold
285
﹤0.01% 1801
2019
Q3
$12K Buy
285
+70
+33% +$2.95K ﹤0.01% 1745
2019
Q2
$14K Hold
215
﹤0.01% 1670
2019
Q1
$15K Hold
215
﹤0.01% 1663
2018
Q4
$9K Hold
215
﹤0.01% 1681
2018
Q3
$16K Sell
215
-60
-22% -$4.47K ﹤0.01% 1589
2018
Q2
$21K Buy
275
+100
+57% +$7.64K ﹤0.01% 1533
2018
Q1
$9K Buy
+175
New +$9K ﹤0.01% 1688
2017
Q2
Sell
-270
Closed -$18K 1860
2017
Q1
$18K Sell
270
-230
-46% -$15.3K ﹤0.01% 1530
2016
Q4
$35K Hold
500
﹤0.01% 1488
2016
Q3
$35K Buy
500
+200
+67% +$14K ﹤0.01% 1468
2016
Q2
$15K Hold
300
﹤0.01% 1712
2016
Q1
$19K Buy
+300
New +$19K ﹤0.01% 1627